Smart Meter and digiiMED Release Hypertension Management Pilot Program Results

Smart Meter and digiiMED are sharing (and touting) positive results of a high-impact hypertension management pilot conducted across three Federally Qualified Health Centers (FQHCs) in Puerto Rico. digiiMED also announced plans to expand its offering into the continental United States, bringing its RPM and clinical services model—powered by Smart Meter cellular devices—to FQHCs and underserved patient populations nationwide.

Funded by the Puerto Rico Primary Care Association (PRPCA), the program was implemented between May and September 2025. digiiMED was awarded the initiative through a competitive RFP process and provided bilingual, culturally-competent clinical care management, project management, data analysis, and Smart Meter’s iBloodPressure cellular-enabled monitoring devices.

The pilot demonstrates the measurable impact of combining cellular-connected RPM technology with proactive clinical engagement to improve chronic disease outcomes in underserved populations and establishes a blueprint for broader U.S. deployment, according to the companies.

Strong Enrollment, Engagement, and Data Capture

The program enrolled 360 patients with uncontrolled hypertension, identified based on their most recently documented blood pressure readings. The average patient age was 66, reflecting a high-risk population with a significant need for ongoing monitoring and intervention.

Enrollment was completed by July 2025, and patient engagement remained strong throughout the pilot:

• 333 patients actively transmitted readings
• Patients averaged 14 readings per patient per month
• More than 23,000 blood pressure readings were collected
• Data was seamlessly integrated into patient charts within their electronic health record (EHR) platform following RPM program activation

This consistent flow of actionable data enabled care teams to intervene earlier, adjust treatment plans, and maintain continuous visibility into patient status outside the clinic.

Clinically Meaningful Outcomes Achieved

A retrospective analysis of 179 patients meeting study criteria revealed significant improvements in blood pressure control and overall hypertension management:

• 30% achieved clinically meaningful improvement
• 54% of patients with uncontrolled hypertension reached blood pressure control by the end of the program

The program’s primary objective was to support blood pressure control aligned with HRSA Uniform Data System (UDS) Blood Pressure Control metrics, a key quality benchmark for FQHCs. Results underscore RPM’s effectiveness as a scalable solution for improving chronic disease outcomes while supporting regulatory reporting and value-based care performance, Smart Meter executives claim.

“This program validates what is possible when reliable, always-connected technology is paired with proactive, clinical engagement,” Smart Meter CEO Casey Pittock stated. “We are excited to support digiiMED’s expansion into the U.S. market and to bring this model to FQHCs nationwide that are seeking scalable ways to improve hypertension control, meet quality metrics, and enhance patient access to care.”

Expansion Into the U.S. FQHC Market

Building on the success of the Puerto Rico pilot, digiiMED is formalizing a strategic expansion into the broader U.S. market, with an initial focus on FQHCs and other safety-net providers managing high rates of uncontrolled chronic disease.

digiiMED plans to introduce its bilingual, culturally-competent, clinically-integrated RPM services model to U.S.-based health centers, leveraging Smart Meter’s fully cellular device ecosystem and established national distribution footprint.

“The results in Puerto Rico demonstrate both clinical impact and operational scalability,” digiiMED CEO José Alvarez said. “As we expand into the United States, our goal is to help more FQHCs and primary care organizations improve outcomes for high-risk populations through a seamless combination of connected devices, bilingual clinical support, and actionable data.”

The pilot reinforces remote patient monitoring as a powerful tool for FQHCs and primary care organizations seeking to improve quality scores, increase patient engagement, and succeed under value-based reimbursement models, according to both companies.

Since 2016, customers have hired Smart Meter to help remotely capture and deliver accurate patient vitals securely and reliably. Today, Smart Meter is considered the top trusted supplier of cellular-enabled remote patient monitoring solutions, delivering reliable, real-time patient data to healthcare providers, payers, and technology partners. With millions of vitals transmitted through its exclusive private data network for RPM, Smart Meter empowers organizations to securely improve patient outcomes, reduce hospitalizations, and optimize reimbursement.

digiiMED LLC is a digital health services and consulting company focused on improving care for patients with chronic conditions. Through the use of digital devices, data-driven information systems, and dedicated clinical personnel, digiiMED ensures care continuity and enables early detection of health risks. digiiMED empowers healthcare professionals with timely biometric and qualitative data to support informed clinical decision-making, while equipping patients with education, resources, and improved access to clinical services. digiiMED’s model promotes timely intervention, reduces the need for high-cost acute care, and fosters a culture centered on prevention. By aligning technology, clinical oversight, and patient engagement, digiiMED strives to deliver better health outcomes and positively impact the quality of life of Spanish-speaking patient populations across the United States and its territories.